Transapical Off-Pump Valve-in-Valve Implantation in Patients With Degenerated Aortic Xenografts

被引:66
作者
Kempfert, Joerg
Van Linden, Arnaud
Linke, Axel
Borger, Michael A.
Rastan, Ardawan
Mukherjee, Chirojit
Ender, Joerg
Schuler, Gerhard
Mohr, Friedrich W.
Walther, Thomas [1 ]
机构
[1] Univ Leipzig, Herzzentrum, Klin Herzchirurg, D-04299 Leipzig, Germany
关键词
REPLACEMENT; BIOPROSTHESIS; REGURGITATION; PROSTHESIS; STENOSIS;
D O I
10.1016/j.athoracsur.2010.02.061
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. The reoperative risk for degenerated aortic valve xenografts may be increased in elderly patients with comorbidities. We evaluated the off-pump beating heart concept of transapical aortic valve implantation using the valve-in-valve (VinV) concept. Methods. Since March 2007, 11 patients with degenerated xenografts received transapical aortic valve implantation using the Edwards Sapien transcatheter heart valve (Edwards Lifesciences, Irvine, CA). After informed consent, all procedures were performed as an off-label use. Mean patient age was 78 +/- 6 years (range, 72 to 89), mean logistic European System for Cardiac Operative Risk Evaluation was 32% +/- 16% (range, 16% to 62%) and mean Society for Thoracic Surgeons score was 7% +/- 3% (range, 3% to 10%). Results. All patients were treated off pump. The transapical aortic valve implantation was successful in all patients, and apical access was uncomplicated in all of them. Total operating room time was 71 +/- 14 minutes. On postoperative echocardiography, there was no paravalvular incompetence in any and mild (first degree) central incompetence in 2 of 11 patients. Sufficient flaring of the inflow and outflow parts of the Sapien prosthesis was observed in all patients, suggesting a stable position and an almost absent risk of late embolization. Maximal transvalvular pressure gradients were 21 +/- 8 mm Hg, and mean echocardiographic pressure gradients were 11 +/- 4 mm Hg. Follow-up extends to 330 +/- 293 days (range, 15 to 1,007), and all patients are well and alive. Conclusions. Valve-in-valve implantation is a truly minimally invasive procedure for redo treatment of failed aortic valve xenografts in high-risk elderly patients. The Edwards Sapien valve is well suited for VinV implantation, and this technique may become a routine procedure to treat degenerated xenografts in the future. (Ann Thorac Surg 2010; 89: 1934-41) (C) 2010 by The Society of Thoracic Surgeons
引用
收藏
页码:1934 / 1941
页数:8
相关论文
共 20 条
[1]   ACC/AHA 2006 guidelines for the management of patients with valvular heart disease [J].
Bonow, Robert O. ;
Carabello, Blase A. ;
Chatterjee, Kanu ;
de Leon, Antonio C., Jr. ;
Faxon, David P. ;
Freed, Michael D. ;
Gaasch, William H. ;
Lytle, Bruce Whitney ;
Nishimura, Rick A. ;
O'Gara, Patrick T. ;
O'Rourke, Robert A. ;
Otto, Catherine M. ;
Shah, Pravin M. ;
Shanewise, Jack S. ;
Smith, Sidney C., Jr. ;
Jacobs, Alice K. ;
Adams, Cynthia D. ;
Anderson, Jeffrey L. ;
Antman, Elliott M. ;
Faxon, David P. ;
Fuster, Valentin ;
Halperin, Jonathan L. ;
Hiratzka, Loren F. ;
Hunt, Sharon A. ;
Lytle, Bruce W. ;
Nishimura, Rick ;
Page, Richard L. ;
Riegel, Barbara .
CIRCULATION, 2006, 114 (05) :E84-E231
[2]  
BRUSCHI G, 2009, J CARDIOVASC ME 1013
[3]   Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis - First human case description [J].
Cribier, A ;
Eltchaninoff, H ;
Bash, A ;
Borenstein, N ;
Tron, C ;
Bauer, F ;
Derumeaux, G ;
Anselme, F ;
Laborde, F ;
Leon, MB .
CIRCULATION, 2002, 106 (24) :3006-3008
[4]   Percutaneous aortic valve replacement for severe aortic stenosis in high-rick patients using the second- and current third-generation self-expanding CoreValve prosthesis - Device success and 30-day clinical outcome [J].
Grube, Eberhard ;
Schuler, Gerhard ;
Buellesfeld, Lutz ;
Gerckens, Ulrich ;
Linke, Axel ;
Wenaweser, Peter ;
Sauren, Barthel ;
Mohr, Friedrich-Wilhelm ;
Walther, Thomas ;
Zickmann, Bernfried ;
Iversen, Stein ;
Felderhoff, Thomas ;
Cartier, Raymond ;
Bonan, Raoul .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (01) :69-76
[5]   Cardiac Surgery in Germany during 2008. A Report on Behalf of the German Society for Thoracic and Cardiovascular Surgery [J].
Gummert, J. F. ;
Funkat, A. ;
Beckmann, A. ;
Schiller, W. ;
Hekmat, K. ;
Ernst, M. ;
Haverich, A. .
THORACIC AND CARDIOVASCULAR SURGEON, 2009, 57 (06) :315-323
[6]   Minimally invasive transapical aortic valve-in-a-valve implantation for severe aortic regurgitation in a degenerated stentless bioprosthesis [J].
Kelpis, Timotheos G. ;
Mezilis, Nikolaos E. ;
Ninios, Vlasis N. ;
Pitsis, Antonis A. .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2009, 138 (04) :1018-1020
[7]   Minimally Invasive Off-Pump Aortic Valve Implantation: The Surgical Safety Net [J].
Kempfert, Joerg ;
Walther, Thomas ;
Borger, Michael A. ;
Lehmann, Sven ;
Blumenstein, Johannes ;
Fassl, Jens ;
Schuler, Gerhard ;
Mohr, Friedrich-Wilhelm .
ANNALS OF THORACIC SURGERY, 2008, 86 (05) :1665-1668
[8]   Minimally invasive off-pump valve-in-a-valve implantation: the atrial transcatheter approach for re-operative mitral valve replacement [J].
Kempfert, Jorg ;
Blumenstein, Johannes M. ;
Borger, Michael A. ;
Linke, Axel ;
Lehmann, Sven ;
Pritzwald-Stegmann, Patrick ;
Chu, Michael W. A. ;
Schuler, Gerhard ;
Falk, Volkmar ;
Mohr, Friedrich Wilhelm ;
Walther, Thomas .
EUROPEAN HEART JOURNAL, 2008, 29 (19) :2382-2387
[9]   Transapical Transcatheter Treatment of a Stenosed Aortic Valve Bioprosthesis Using the Edwards SAPIEN Transcatheter Heart Valve [J].
Klaaborg, Kaj-Erik ;
Egeblad, Henrik ;
Jakobsen, Carl-Johan ;
Lindskov, Christian ;
Andersen, Henning Rud ;
Thuesen, Leif .
ANNALS OF THORACIC SURGERY, 2009, 87 (06) :1943-1946
[10]  
MAROTO LC, 2009, J CARDIOTHORAC 1014